A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Public ClinicalTrials.gov record NCT03536884. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Secukinumab-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study to compare the efficacy of bimekizumab versus secukinumab in subjects with moderate to severe chronic plaque psoriasis (PSO).
Study identification
- NCT ID
- NCT03536884
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 743 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 13, 2018 (Actual)
- Primary completion
- Sep 12, 2019 (Actual)
- Completion
- Aug 9, 2023 (Actual)
- Last update posted
- Apr 15, 2026
2018 – 2023
United States locations
- U.S. sites
- 25
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ps0015 975 | Santa Ana | California | 92701 | — |
| Ps0015 939 | Danbury | Connecticut | 06810 | — |
| Ps0015 903 | Ocala | Florida | 34470 | — |
| Ps0015 921 | Ormond Beach | Florida | 32174 | — |
| Ps0015 977 | Pembroke Pines | Florida | 33028 | — |
| Ps0015 936 | Tampa | Florida | 33613 | — |
| Ps0015 976 | Tampa | Florida | 33614 | — |
| Ps0015 970 | West Palm Beach | Florida | 33409 | — |
| Ps0015 966 | Sandy Springs | Georgia | 30328 | — |
| Ps0015 954 | Skokie | Illinois | 60077 | — |
| Ps0015 972 | West Dundee | Illinois | 60118 | — |
| Ps0015 900 | West Des Moines | Iowa | 50265 | — |
| Ps0015 944 | New Orleans | Louisiana | 70115 | — |
| Ps0015 915 | Clayton | Missouri | 63105 | — |
| Ps0015 953 | St Louis | Missouri | 63141 | — |
| Ps0015 901 | Portsmouth | New Hampshire | 03801 | — |
| Ps0015 965 | Kew Gardens | New York | 11415 | — |
| Ps0015 969 | High Point | North Carolina | 27262 | — |
| Ps0015 971 | Wilmington | North Carolina | 28405 | — |
| Ps0015 980 | Bexley | Ohio | 43209 | — |
| Ps0015 920 | Portland | Oregon | 97210 | — |
| Ps0015 929 | Portland | Oregon | 97223 | — |
| Ps0015 979 | Dallas | Texas | 75246 | — |
| Ps0015 924 | Houston | Texas | 77004 | — |
| Ps0015 978 | Pflugerville | Texas | 78660 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03536884, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 15, 2026 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03536884 live on ClinicalTrials.gov.